ResearcherUniversity of Mississippi Medical CenterActive in the last 2 years

Gopalakrishnan Ramakrishnan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5068-6886; OpenAlex author ID A5003812373, A5124930541. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2026.117066 ↗
NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2022.111623 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Creighton Friend · 2 shared papers, 2022–2026 · strength 0.46
- Paper NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2026.117066 ↗
- Paper NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2022.111623 ↗
Parash Parajuli · 2 shared papers, 2022–2026 · strength 0.46
- Paper NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2026.117066 ↗
- Paper NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2022.111623 ↗
Eric G. Hurwitz · 2 shared papers, 2022–2026 · strength 0.46
- Paper NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2026.117066 ↗
- Paper NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2022.111623 ↗
Mohammed Shawkat Razzaque · 2 shared papers, 2022–2026 · strength 0.46
- Paper NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2026.117066 ↗
- Paper NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2022.111623 ↗
Keli Xu · 2 shared papers, 2022–2026 · strength 0.46
- Paper NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2026.117066 ↗
- Paper NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2022.111623 ↗
Azeddine Atfi · 2 shared papers, 2022–2026 · strength 0.46
- Paper NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2026.117066 ↗
- Paper NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2022.111623 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.